Alice Valder Curran advises pharmaceutical manufacturers on drug pricing matters, with emphasis on the Medicaid Drug Rebate Program, the Medicare average sales price (ASP) reporting requirement, the Health Resources and Services Administration (HRSA) 340B Drug Pricing Program, and the recently enacted Inflation Reduction Act (IRA).
Alice works with executives on the government pricing (GP) implications of common commercial strategies. Alice helps manufacturers to review product portfolios and identify the impacts the IRA may have. She also works with commercial and finance personnel on implementing GP obligations and the IRA’s provisions. She also works collaboratively on enforcement matters, often taking the lead with enforcement authorities on Medicaid, Medicare, and 340B programs.
Alice received her J.D. at Columbia Law School and her B.A. cum laude at Pomona College. She also passed the Bar admissions in D.C. and has received awards such as the Regulatory Attorney of the Year: Pricing and Reimbursement, LMG Life Sciences.